- Home
- MEDP vs MBLY Comparison
MEDP vs MBLY Comparison
Compare MEDP & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- MBLY
- Stock Information
- Founded
- MEDP 1992
- MBLY 1999
- Country
- MEDP United States
- MBLY Israel
- Employees
- MEDP N/A
- MBLY N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- MBLY Computer Software: Prepackaged Software
- Sector
- MEDP Health Care
- MBLY Technology
- Exchange
- MEDP Nasdaq
- MBLY Nasdaq
- Market Cap
- MEDP 13.4B
- MBLY 11.2B
- IPO Year
- MEDP 2016
- MBLY 2022
- Fundamental
- Price
- MEDP $490.77
- MBLY $13.78
- Analyst Decision
- MEDP Hold
- MBLY Buy
- Analyst Count
- MEDP 11
- MBLY 17
- Target Price
- MEDP $424.10
- MBLY $20.06
- AVG Volume (30 Days)
- MEDP 320.7K
- MBLY 4.1M
- Earning Date
- MEDP 10-20-2025
- MBLY 10-30-2025
- Dividend Yield
- MEDP N/A
- MBLY N/A
- EPS Growth
- MEDP 26.42
- MBLY N/A
- EPS
- MEDP 13.46
- MBLY N/A
- Revenue
- MEDP $2,231,787,000.00
- MBLY $1,920,000,000.00
- Revenue This Year
- MEDP $19.06
- MBLY $13.66
- Revenue Next Year
- MEDP $8.64
- MBLY $9.95
- P/E Ratio
- MEDP $36.52
- MBLY N/A
- Revenue Growth
- MEDP 9.94
- MBLY 4.07
- 52 Week Low
- MEDP $250.05
- MBLY $10.62
- 52 Week High
- MEDP $501.30
- MBLY $22.51
- Technical
- Relative Strength Index (RSI)
- MEDP 62.33
- MBLY 43.75
- Support Level
- MEDP $485.33
- MBLY $13.56
- Resistance Level
- MEDP $498.15
- MBLY $14.26
- Average True Range (ATR)
- MEDP 11.60
- MBLY 0.48
- MACD
- MEDP -1.73
- MBLY -0.00
- Stochastic Oscillator
- MEDP 76.38
- MBLY 19.88
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.